1.The Role of Risk-sharing Mechanisms in Finance Health Care and Towards Universal Health Coverage in Low-and Middle-income Countries of World Health Organization Regions
Ali AHANGAR ; Ali Mohammad AHMADI ; Amir Hossein MOZAYANI ; Sajjad Faraji DIZAJI
Korean Journal of Preventive Medicine 2018;51(1):59-61
No abstract available.
Delivery of Health Care
;
Global Health
;
World Health Organization
2.WHO global strategy on digital health and its implications to China.
Peng XUE ; An Ying BAI ; Yu JIANG ; You Lin QIAO
Chinese Journal of Preventive Medicine 2022;56(2):218-221
The World Health Organization (WHO) released the global strategy report on digital health (2020-2025) in Geneva in 2019, which established the priority of the digital health strategy and formulated strategic objectives, guiding principles, action framework and implementation plans to promote the development of global digital health, and to achieve universal health coverage and the health-related sustainable development goals. Despite China's rapid development in the field of digital health, there is still a big gap between the realization of the goal of digital health. Therefore, it is urgent to grasp the major historical opportunity and step into a new era of digital health with the support of digital technology platform.
China
;
Global Health
;
Humans
;
Universal Health Insurance
;
World Health Organization
5.Vision 2020 and prevention of blindness: is it relevant or achievable in the modern era?
Annals of the Academy of Medicine, Singapore 2006;35(3):215-222
We are living in exciting times with many challenges and new opportunities to overcome diseases. The concept and definition of blindness and their major causes worldwide are discussed with reference to the Vision 2020 initiatives launched in 1999 for blindness prevention, with an updated summary. The peculiar problems that exists in Singapore are also presented. Yet, if the world's major causes of blindness: cataracts, onchocerciasis, trachoma, refractive errors and low vision, and childhood blindness (inherent problems of the Third and Fourth World) can be overcome with international concerted efforts by year 2020, there will emerge new causes as yet unknown. Noble as our aims may be to achieve short- and long-term targets, we have to face the continuous reality of our inability to fulfil them.
Blindness
;
etiology
;
prevention & control
;
Global Health
;
Healthy People Programs
;
Humans
;
World Health Organization
6.What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?.
Jooae CHOE ; Kyung Won KIM ; Hyoung Jung KIM ; Dong Wook KIM ; Kyu Pyo KIM ; Seung Mo HONG ; Jin Sook RYU ; Sree Harsha TIRUMANI ; Katherine KRAJEWSKI ; Nikhil RAMAIYA
Korean Journal of Radiology 2019;20(1):5-17
The diagnosis and management of pancreatic neuroendocrine neoplasms (NENs) have evolved significantly in recent years. There are several diagnostic and therapeutic challenges and controversies regarding the management of these lesions. In this review, we focus on the recent significant changes and controversial issues regarding the diagnosis and management of NENs and discuss the role of imaging in the multidisciplinary team approach.
Diagnosis
;
Global Health*
;
Joints*
;
Neoplasm Staging*
;
Neuroendocrine Tumors
;
Pancreas
;
World Health Organization*
7.Treatment Decisions of World Health Organization Grade II and III Ependymomas in Molecular Era
Tae Young JUNG ; Shin JUNG ; Hoon KOOK ; Hee Jo BAEK
Journal of Korean Neurosurgical Society 2018;61(3):312-318
Surgery and radiotherapy are mainstays of treatment for ependymomas (EPNs). Recent molecular subgrouping could be superior to histopathological grading for predicting the prognosis of patients with EPNs. Gross total resection is an effective treatment approach regardless of its locations or pathologic grades. Adjuvant therapeutic strategies could be decided based on molecular subgrouping with risk-stratification. Information of histologic-molecular biology is now providing clues to therapeutic insights.
Biology
;
Ependymoma
;
Global Health
;
Humans
;
Molecular Medicine
;
Prognosis
;
Radiotherapy
;
World Health Organization
8.Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria
Ik Chan SONG ; Yoon Seok CHOI ; Jong Wook SHIN ; Hee Jung SONG ; Jei KIM ; Deog Yeon JO
Blood Research 2019;54(4):284-285
No abstract available.
Cerebral Infarction
;
Global Health
;
Humans
;
Mass Screening
;
Retrospective Studies
;
World Health Organization
9.Colorectal cancer incidence and mortality: the current status, temporal trends and their attributable risk factors in 60 countries in 2000-2019.
Bin LU ; Na LI ; Chen-Yu LUO ; Jie CAI ; Ming LU ; Yu-Han ZHANG ; Hong-Da CHEN ; Min DAI
Chinese Medical Journal 2021;134(16):1941-1951
BACKGROUND:
Globally, colorectal cancer (CRC) imposes a substantial burden on healthcare systems and confers considerable medical expenditures. We aimed to evaluate the global and regional burden in epidemiological trends and factors associated with the incidence and mortality of CRC.
METHODS:
We used data from the GLOBOCAN database to estimate CRC incidence and mortality worldwide in 2020 and their association with the human development index (HDI). Trends of age-standardized rates of incidence and mortality in 60 countries (2000-2019) were evaluated by Joinpoint regression analysis using data of Global Burden of Disease 2019. The association between exposure to country-level lifestyle, metabolic and socioeconomic factors obtained from the World Health Organization Global Health Observatory and World Bank DataBank data and CRC incidence and mortality was determined by multivariable linear regression.
RESULTS:
CRC incidence and mortality varied greatly in the 60 selected countries, and much higher incidence and mortality were observed in countries with higher HDIs, and vice versa. From 2000 to 2019, significant increases of incidence and mortality were observed for 33 countries (average annual percent changes [AAPCs], 0.24-3.82) and 18 countries (AAPCs, 0.41-2.22), respectively. A stronger increase in incidence was observed among males (AAPCs, 0.36-4.54) and individuals <50 years (AAPCs, 0.56-3.86). Notably, 15 countries showed significant decreases in both incidence (AAPCs, -0.24 to -2.19) and mortality (AAPCs, -0.84 to -2.74). A significant increase of incidence among individuals <50 years was observed in 30 countries (AAPCs, 0.28-3.62). Countries with higher incidence were more likely to have a higher prevalence of alcohol drinking, higher level of cholesterol level, higher level of unemployment, and a poorer healthcare system.
CONCLUSIONS
Some high-HDI countries showed decreasing trends in CRC incidence and mortality, whereas developing countries that previously had low disease burden showed significantly increased incidence and mortality trends, especially in males and populations ≥50 years, which require targeted preventive health programs.
Colorectal Neoplasms/epidemiology*
;
Global Health
;
Humans
;
Incidence
;
Male
;
Risk Factors
;
World Health Organization
10.Interpretation of defeating meningitis by 2030: a global road map.
Hui ZHENG ; Ming Shuang LI ; Dan WU ; Ting Ting YAN ; Zhi Jie AN ; Yi Xing LI
Chinese Journal of Preventive Medicine 2022;56(9):1348-1352
Meningitis is a life-threatening disease. In order to reduce its threat to public health, the World Health Assembly indorsed a resolution in 2020 for urgent global action to prevent and control meningitis. Defeating Meningitis by 2030: a Global Roadmap was officially launched by the World Health Organization in 2021. We interpreted some key information of the roadmap from the aspects of coverage, objectives and pillar strategies, providing ideas for further strengthening the prevention and control of bacterial meningitis in China.
China/epidemiology*
;
Global Health
;
Humans
;
Meningitis, Bacterial/prevention & control*
;
World Health Organization